Which hedge funds own KROS? KEROS THERAPEUTICS INC, Q2 2026 13F holders
22 tracked hedge funds disclosed a position in KROS (KEROS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $70.8m in total. The largest holder by portfolio weight is Nantahala Capital Management, LLC at 0.9% of its book. 3 opened a new position this quarter: Jain Global LLC, Squarepoint Ops LLC, Marshall Wace, LLP. 5 exited: Oxford Asset Management LLP, Fox Run Management, L.L.C., Magnetar Financial LLC.
- 22
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 3
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $1.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $1.2m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $70.8m
- Combined value Sum of the holders' reported positions in the security.
- 1.8%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Oxford Asset Management LLP | 0.05% | $123k |
| Fox Run Management, L.L.C. | 0.04% | $243k |
| Magnetar Financial LLC | 0.0% | $332k |
| Tudor Investment Corp ET AL | 0.0% | $309k |
| Brevan Howard Capital Management LP | 0.0% | $162k |
Ownership over time
Who discovered KROS first? Beta
| Logos Global Management LP high conviction | Q3 2020 | +8.4 pts |
| Venrock Adviser, LLC high conviction | Q2 2020 | +2.7 pts |
| Opaleye Management Inc. high conviction | Q4 2021 | +2.4 pts |
| RA Capital Management, L.P. | Q2 2020 | +1.1 pts |
| Orbimed Advisors LLC | Q2 2020 | −0.2 pts |
| Nantahala Capital Management, LLC | Q4 2020 | −0.4 pts |
| Fairmount Funds Management LLC high conviction | Q1 2021 | −2.3 pts |
| Darwin Global Management, Ltd. high conviction | Q4 2022 | −3.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.